Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4229.46 | 459 / 459 | 100% | 24.95 | 1118 / 1118 |
ovary | 100% | 2753.92 | 180 / 180 | 100% | 15.59 | 430 / 430 |
uterus | 100% | 5781.17 | 170 / 170 | 100% | 16.54 | 459 / 459 |
intestine | 100% | 3531.28 | 965 / 966 | 100% | 11.16 | 527 / 527 |
thymus | 100% | 3603.32 | 652 / 653 | 100% | 20.21 | 604 / 605 |
esophagus | 100% | 4824.62 | 1440 / 1445 | 100% | 13.38 | 183 / 183 |
lung | 100% | 3266.65 | 576 / 578 | 100% | 16.02 | 1155 / 1155 |
bladder | 100% | 4021.62 | 21 / 21 | 100% | 12.15 | 502 / 504 |
prostate | 100% | 4006.71 | 244 / 245 | 100% | 17.34 | 502 / 502 |
skin | 100% | 3631.76 | 1807 / 1809 | 100% | 18.23 | 470 / 472 |
brain | 99% | 3793.94 | 2621 / 2642 | 100% | 17.88 | 705 / 705 |
kidney | 100% | 2633.66 | 89 / 89 | 99% | 13.80 | 893 / 901 |
stomach | 99% | 2426.83 | 356 / 359 | 100% | 12.17 | 285 / 286 |
adrenal gland | 100% | 2503.35 | 258 / 258 | 97% | 12.08 | 224 / 230 |
liver | 96% | 1443.32 | 218 / 226 | 100% | 11.68 | 405 / 406 |
pancreas | 95% | 1527.83 | 312 / 328 | 100% | 12.47 | 178 / 178 |
adipose | 100% | 4148.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6345.91 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.62 | 29 / 29 |
muscle | 100% | 8871.20 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2634.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.03 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.12 | 1 / 1 |
heart | 99% | 6848.15 | 849 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 13.62 | 77 / 80 |
peripheral blood | 69% | 1421.93 | 642 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0016567 | Biological process | protein ubiquitination |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF115 |
Protein name | E3 ubiquitin-protein ligase RNF115 (EC 2.3.2.27) (RING finger protein 115) (RING-type E3 ubiquitin transferase RNF115) (Rab7-interacting RING finger protein) (Rabring 7) (Zinc finger protein 364) |
Synonyms | ZNF364 |
Description | FUNCTION: E3 ubiquitin-protein ligase that catalyzes the 'Lys-48'- and/or 'Lys-63'-linked polyubiquitination of various substrates and thereby plays a role in a number of signaling pathways including autophagy, innate immunity, cell proliferation and cell death . Plays a role in the endosomal trafficking and degradation of membrane receptors including EGFR, FLT3, MET and CXCR4 through their polyubiquitination. Participates together with BST2 in antiviral immunity by facilitating the internalization of HIV-1 virions into intracellular vesicles leading to their lysosomal degradation . Possesses also an antiviral activity independently of BST2 by promoting retroviral GAG proteins ubiquitination, redistribution to endo-lysosomal compartments and, ultimately, lysosomal degradation . Catalyzes distinct types of ubiquitination on MAVS and STING1 at different phases of viral infection to promote innate antiviral response . Mediates the 'Lys-48'-linked ubiquitination of MAVS leading to its proteasomal degradation and ubiquitinates STING1 via 'Lys-63'-linked polyubiquitination, critical for its oligomerization and the subsequent recruitment of TBK1 . Plays a positive role in the autophagosome-lysosome fusion by interacting with STX17 and enhancing its stability without affecting 'Lys-48'- or 'Lys-63'-linked polyubiquitination levels, which in turn promotes autophagosome maturation . Negatively regulates TLR-induced expression of proinflammatory cytokines by catalyzing 'Lys-11'-linked ubiquitination of RAB1A and RAB13 to inhibit post-ER trafficking of TLRs to the Golgi by RAB1A and subsequently from the Golgi apparatus to the cell surface by RAB13 . . |
Accessions | ENST00000582693.5 Q9Y4L5 |